GlassScriptPhysician profile
David W Hoerner
NPI 1801849047
$4,127.66
in general payments reported to CMS, 2019-2025
35 companies · $594 in 2025
The $594 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $242 · 2021: $399 · 2022: $867 · 2023: $927 · 2024: $905 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,425.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $598.64 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $399.61 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $371.63 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $352.30 | 2021-2025 | |
| Pfizer INC. | $274.58 | 2019-2025 | |
| Exeltis, USA INC. | $264.94 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $223.69 | 2020-2025 | |
| Organon LLC | $203.90 | 2022-2025 | Nexplanon, Jada System |
| Amgen INC. | $184.80 | 2020-2024 | Evenity, Prolia |
| Millicent US INC | $156.66 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Hologic Sales and Service, LLC | $116.55 | 2022-2025 | Aptima |
| Therapeuticsmd, INC. | $112.16 | 2019-2022 | |
| Avion Pharmaceuticals | $107.18 | 2020-2023 | Balcoltra |
| Mylan Pharmaceuticals INC. | $100.94 | 2020-2022 | |
| Ethicon US, LLC | $83.25 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $68.85 | 2022 | |
| Merck Sharp & Dohme LLC | $63.51 | 2019-2020 | |
| Myovant Sciences INC. | $59.83 | 2021-2022 | |
| Biom'Up France Sas | $47.12 | 2021 | |
| Coopersurgical, INC. | $43.58 | 2019-2021 | |
| Scynexis, INC. | $37.18 | 2022 | |
| Stryker Corporation | $32.08 | 2023 | 1788 |
| Minerva Surgical, INC | $26.69 | 2020-2021 | |
| Inari Medical, INC. | $25.39 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mycovia Pharmaceuticals, INC. | $24.69 | 2023 | Vivjoa |
| Agile Therapeutics, INC. | $20.15 | 2021 | |
| Convatec INC. | $19.07 | 2022 | |
| Meditrina | $17.37 | 2025 | |
| Coloplast Corp | $17.21 | 2023 | Altis |
| Shield Therapeutics INC | $16.64 | 2023 | Accrufer |
| Ibsa Pharma INC. | $14.08 | 2023 | Tirosint, Licart |
| Vertex Pharmaceuticals Incorporated | $13.49 | 2024 | |
| Amag Pharmaceuticals, INC. | $12.84 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.76 | 2020 | |
| Evofem Biosciences, INC. | $4.30 | 2025 | Solosec, Phexx, Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hoerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.